Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping
PHASE3
The aim of this study is to demonstrate that clazosentan, administered as a...
Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain
PHASE3
This study will evaluate if clazosentan (on top of normal routine medical c...
Status
Completed
Location
Stanford Hospital & Clinics - Stanford School of Medicine Dept. of Neurosurgery